Fatty acid synthase (FASN), a key complex catalyzing fatty acid synthesis has been found to be linked to acquired docetaxel/trastuzumab/adriamycin resistance in breast cancer or intrinsic gemcitabine and radiation resistance in pancreatic cancer.
Similar resistance have been found with intrinsic gemcitabine and radiation resistance in pancreatic cancer. Fatty acid synthase (FASN), a key complex catalyzing fatty acid synthesis has been found to be linked to acquired docetaxel, trastuzumab and adriamycin resistance in breast cancer.
Fatty acid synthase (FASN), a key complex catalyzing fatty acid synthesis has been found to be linked to acquired docetaxel, trastuzumab and adriamycin resistance in breast cancer. Similar resistance have been found with intrinsic gemcitabine and radiation resistance in pancreatic cancer.
Fatty acid synthase (FASN), a key complex catalyzing fatty acid synthesis has been found to be linked to acquired docetaxel, trastuzumab and adriamycin resistance in breast cancer. Similar resistance have been found with intrinsic gemcitabine and radiation resistance in pancreatic cancer.